HOME >> BIOLOGY >> NEWS
Compound reveals new link between signaling protein and cell migration

University of Illinois at Chicago researchers report that a protein that regulates key signaling pathways in cells also plays a role in controlling the active movement or migration of cells. The finding may suggest new pharmaceutical therapies for treating a variety of diseases, including cancer.

The protein, known as Raf Kinase Inhibitor Protein, or RKIP, controls activity of kinases, a type of enzyme that acts as a key component in the biochemical signaling pathways responsible for determining almost all cellular activity. But RKIP's own activity is inhibited when a small molecule organic compound called locostatin, discovered earlier by UIC researchers, binds to it.

Lead investigator Gabriel Fenteany, assistant professor of chemistry at UIC, reports the finding in the Sept. 26 issue of the journal Chemistry and Biology.

The researchers used an approach sometimes called "forward chemical genetics" whereby they first identified locostatin as an inhibitor of cell migration, then used locostatin itself as a kind of bait to fish out the protein to which it binds. That protein was RKIP.

"We have implicated this protein in controlling cell migration, a role it was not previously known to play," said Fenteany. "It's a molecular target of locostatin. We found this on the basis of the chemical affinity of locostatin for this protein."

As a regulatory protein, RKIP controls the functions of kinases, thereby governing signaling pathways. When these pathways are not properly controlled, all kinds of diseases can result, including cancer.

Fenteany and his team also confirmed that RKIP is involved in cell migration by using other methods.

"After finding that locostatin targets RKIP, we wanted to verify that RKIP really does control cell migration," Fenteany said. The researchers removed, or knocked down, RKIP in the cell using a method called RNA interference and looked at the effect on cell migration. They did the opposit
'"/>

Contact: Paul Francuch
francuch@uic.edu
312-996-3457
University of Illinois at Chicago
26-Sep-2005


Page: 1 2

Related biology news :

1. Scripps research scientists: Compounds show significant promise against potential bioweapon toxins
2. Compound eyes, evolutionary ties
3. Compounds in cranberry juice show promise as alternatives to antibiotics
4. Compound in wine reduces levels of Alzheimers disease-causing peptides
5. Compound from Chinese medicine shows promise in head and neck cancer
6. Animal study: Compounds in cranberries may have heart-healthy effects
7. Compound from Chinese medicine shows promise in head and neck cancer, U-M study finds
8. Compounds in plastic packaging act as environmental estrogens altering breast genes
9. Compound inhibits one critical pathway in breast cancer growth
10. Compound from rare plant shows promise in treating breast cancer
11. Satellite tracking reveals threats to Borneo pygmy elephants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/2/2018)... ... , ... Stuart is a fun-loving eight-year-old Labrador retriever. Like many labs, Stuart’s favorite thing ... playing ball so much that whenever anyone comes to our door, he grabs a toy ... In early 2017, Stuart began limping and eventually could no longer play fetch. ...
(Date:10/2/2018)... ... 02, 2018 , ... The Federal Identity Forum & Exposition ... Center. The Palo Alto-based face recognition company, Camvi Technologies Inc., was invited to ... included U.S. Federal executives from Department of Defense (DoD) and Federal Bureau of ...
(Date:10/1/2018)... BOZEMAN, Mont. (PRWEB) , ... October 01, 2018 ... ... pharmaceutical company advancing targeted antibody drug conjugate (ADC) like, lipid based therapeutics, today ... Research (SBIR) Program had confirmed the award of first year funding for ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... ... October 02, 2018 , ... The Alliance for ... have initiated validation of standards and testing of procedures for voluntary accreditation of ... Kennedy, ACRES VP for Quality Management Systems and Chief Quality Officer, is underway ...
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, Inc. ... availability of the GlycoMark test, the only FDA-cleared blood test specific to detecting ... will promote and offer the GlycoMark test to its network of physicians through ...
(Date:9/27/2018)... ... 26, 2018 , ... NDA Partners Chairman Carl Peck, ... and in vitro diagnostic device expert with more than 28 years of experience ... as an Expert Consultant. Her experience includes leadership roles in regulatory strategy, quality ...
(Date:9/27/2018)... , ... September 26, 2018 , ... ... is a platform that aims to build the first human digitome, a digital ... and real-world data through a seamless integration of all data sources. Dr. Michelle ...
Breaking Biology Technology:
Cached News: